We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Delays PDUFA Date for Somerset's Antidepressant Patch
FDA Delays PDUFA Date for Somerset's Antidepressant Patch
November 22, 2005
The FDA has extended the review period for Somerset Pharmaceuticals’ Emsam, an investigational transdermal patch for the acute and maintenance treatment of major depressive disorder.